rpcardioRational Pharmacotherapy in CardiologyРациональная Фармакотерапия в Кардиологии1819-64462225-3653«SILICEA-POLIGRAF» LLC10.20996/1819-6446-2013-9-1-74-78rpcardio-76Research ArticlePOINT OF VIEWТОЧКА ЗРЕНИЯEFFECT OF DIFFERENT GLUCOSE BLOOD LEVELS ON THE DEVELOPMENT OF CARDIOVASCULAR DISEASES AND COMPLICATIONSЗНАЧЕНИЕ РАЗЛИЧНОГО УРОВНЯ ГЛЮКОЗЫ В РАЗВИТИИ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ И ОСЛОЖНЕНИЙАхмедоваЭ. Б.AkhmedovaE. V.mmamedov@gnicpm.ruТогузоваЗ. А.ToguzovaZ. A.mmamedov@gnicpm.ruМамедовМ. Н.MamedovM. N.mmamedov@gnicpm.ruГосударственный научно-исследовательский центр профилактической медицины, МоскваРоссияState scientific research centre of preventive medicine, MoscowRussian FederationСеверо-Осетинская государственная медицинская академия, ВладикавказРоссияNorth Ossetian State Medical Academy, VladikavkazRussian Federation201321092015917478Copyright © Akhmedova E.V., Toguzova Z.A., Mamedov M.N., 20152015Ахмедова Э.Б., Тогузова З.А., Мамедов М.Н.Akhmedova E.V., Toguzova Z.A., Mamedov M.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.rpcardio.online/jour/article/view/76

Diabetes mellitus (DM) is one of the health and social problems of modern health care. The main causes of death in patients with DM are macrovascular complications. Intensive hypoglycemic therapy is recommended to prevent complications; however it can increase the risk of severe hypoglycemia with subsequent growth rate of mortality. Glucose blood levels should be monitored to reduce the risk of cardiovascular disease and death, as well as control of normoglycemia and risk factors are needed. DM pathogenesis and prevalence are considered, and effects of glucose blood level on its outcomes are analyzed.

Сахарный диабет (СД) является одной из медико-социальных проблем современного здравоохранения. Основной причиной смерти у больных СД являются макрососудистые осложнения. Для предупреждения развития осложнений рекомендуется интенсивная гипогликемическая терапия, которая может повысить риск развития тяжелой гипогликемии с последующим ростом смертности. Для снижения риска развития сердечно-сосудистых заболеваний и смерти необходимо контролировать уровень глюкозы в крови, тщательно обращать внимание на контроль нормогликемии и факторов риска. Рассматривают патогенез и распространенность СД, анализируют влияния уровня гликемии на его исходы.

гликемиясахарный диабетсердечно-сосудистые осложненияglycaemiadiabetescardiovascular complicationsReferencesZimmet P, Dowse G, Finch C, Serjeantson S, King H. The epidemiology and natural history of NIDDMlessons from the South Pacific. Diabetes Metab Res Rev 1990; 6:91–124.Zimmet P, Dowse G, Finch C, Serjeantson S, King H. The epidemiology and natural history of NIDDMlessons from the South Pacific. Diabetes Metab Res Rev 1990; 6:91–124.Ginter E, Simko V. Global prevalence and future of diabetes mellitus. Adv Exp Med Biol. 2012;771:35– 41.Ginter E, Simko V. Global prevalence and future of diabetes mellitus. Adv Exp Med Biol. 2012;771:35– 41.Unwin N, Gan D, Whiting D. The IDF Diabetes altas: providing evidence, raising awareness and promoting action. Diabetes Res Clin Pract 2010; 87: 2–3Unwin N, Gan D, Whiting D. The IDF Diabetes altas: providing evidence, raising awareness and promoting action. Diabetes Res Clin Pract 2010; 87: 2–3Arredondo A. Diabetes: a global challenge with high economic burden for public health systems and society. Am J Public Health 2013;103(2):e1–2.Arredondo A. Diabetes: a global challenge with high economic burden for public health systems and society. Am J Public Health 2013;103(2):e1–2.Demidova I.Yu., Glinkina I.V., Perfilova A.N. Type 2 diabetes mellitus (pathogenesis and treatment). Consilium-Medicum 2000; 2(5): 34–41. Russian (Демидова И.Ю., Глинкина И.В., Перфилова А.Н. Сахарный диабет типа 2 (патогенез и лечение). Consilium-Medicum 2000; 2(5): 34–41).Demidova I.Yu., Glinkina I.V., Perfilova A.N. Type 2 diabetes mellitus (pathogenesis and treatment). Consilium-Medicum 2000; 2(5): 34–41. Russian (Демидова И.Ю., Глинкина И.В., Перфилова А.Н. Сахарный диабет типа 2 (патогенез и лечение). Consilium-Medicum 2000; 2(5): 34–41).Demidova T.Yu., Ametov A.S. Insulin dependent diabetes mellitus – a manifestation of heterogeneous disorders of glucose metabolism. Russkiy Meditsinskiy Zhurnal 1998; 6(12): 757–758. Russian (Демидова Т.Ю., Аметов А.С. Инсулиннезависимый сахарный диабет — проявление гетерогенных нарушений углеводного обмена. Русский Медицинский Журнал 1998; 6(12): 757–758).Demidova T.Yu., Ametov A.S. Insulin dependent diabetes mellitus – a manifestation of heterogeneous disorders of glucose metabolism. Russkiy Meditsinskiy Zhurnal 1998; 6(12): 757–758. Russian (Демидова Т.Ю., Аметов А.С. Инсулиннезависимый сахарный диабет — проявление гетерогенных нарушений углеводного обмена. Русский Медицинский Журнал 1998; 6(12): 757–758).Diedrich L, Sandoval D, Davis SN. Hypoglycemia is connected autonomic failure. Clin Auton Res 2002;12(5):358–65Diedrich L, Sandoval D, Davis SN. Hypoglycemia is connected autonomic failure. Clin Auton Res 2002;12(5):358–65Turnbull FM, Abraira C, Anderson RJ , et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009; 52: 2288–2298.Turnbull FM, Abraira C, Anderson RJ , et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009; 52: 2288–2298.Dluhy RG and McMahon GT. Intensive glucemic control in the ACCORD and ADVANCE trials. N Engl J Med 2008; 358: 2630–2633.Dluhy RG and McMahon GT. Intensive glucemic control in the ACCORD and ADVANCE trials. N Engl J Med 2008; 358: 2630–2633.Gitt AK, Bramlage P, Binz C, et al. (for the DiaRegis Study Group). Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry .Eur J Prev Cardiol 2012; 19(4):765–72.Gitt AK, Bramlage P, Binz C, et al. (for the DiaRegis Study Group). Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry .Eur J Prev Cardiol 2012; 19(4):765–72.Anand SS, Dagenais GR, Mohan V, et al. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study. Eur J Card Prev Rehab 2012; 19(4):755–64.Anand SS, Dagenais GR, Mohan V, et al. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study. Eur J Card Prev Rehab 2012; 19(4):755–64.Sarwar N, Gao P , Seshasai SR, et al. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease : a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375(9733): 2215–2222.Sarwar N, Gao P , Seshasai SR, et al. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease : a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375(9733): 2215–2222.Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160–7.Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160–7.2006 WHO/IDF Guidelines on the diagnostic criteria for diabetes and impaired glycaemic regulation. Diabetes Medicine 23 (Suppl 4); 2006: 570–576.2006 WHO/IDF Guidelines on the diagnostic criteria for diabetes and impaired glycaemic regulation. Diabetes Medicine 23 (Suppl 4); 2006: 570–576.Healthcare in Russia. Statistical Yearbook. Moscow: Rosstat, 2009. Russian (Здравоохранение в Росcии. Статистические сборник. М.: Росстат; 2009).Healthcare in Russia. Statistical Yearbook. Moscow: Rosstat, 2009. Russian (Здравоохранение в Росcии. Статистические сборник. М.: Росстат; 2009).Lowel H, Koenig W, Engel S, et al. The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register followup study. Diabetologia 2000; 43: 218–226.Lowel H, Koenig W, Engel S, et al. The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register followup study. Diabetologia 2000; 43: 218–226.Johnston CS, Sidney S, Bernstein AL, Gress DR. A comparison of risk factors for recurrent TIA and stroke in patients diagnosed with TIA. Neurology 2003; 28: 280–285Johnston CS, Sidney S, Bernstein AL, Gress DR. A comparison of risk factors for recurrent TIA and stroke in patients diagnosed with TIA. Neurology 2003; 28: 280–285Meijer WT, Hoes AW, Rutgers D et al. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vac Biol 1998; 18: 185–192.Meijer WT, Hoes AW, Rutgers D et al. Peripheral arterial disease in the elderly: the Rotterdam Study. Arterioscler Thromb Vac Biol 1998; 18: 185–192.

The authors declare that there are no conflicts of interest present.